University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine Gastroenterology

Topics

• Hepatitis C virus research 241
• Liver Disease Diagnosis and Treatment 135
• Liver Disease and Transplantation 73
• Pancreatitis Pathology and Treatment 69
• Gallbladder and Bile Duct Disorders 67
• Pancreatic and Hepatic Oncology Research 61
• Alcohol Consumption and Health Effects 36
• Inflammatory Bowel Disease 31
• Prenatal Substance Exposure Effects 29
• Helicobacter pylori-related gastroenterology studies 27
• Drug-Induced Hepatotoxicity and Protection 26
• Alcoholism and Thiamine Deficiency 25

Most cited

1. Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis.

   The New England journal of medicine · 2024 · 761 citations · Eric Lawitz

2. A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis.

   The New England journal of medicine · 2024 · 417 citations · Eric Lawitz

3. Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 829 citations · Prabhleen Chahal

4. Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial.

   The lancet. Gastroenterology & hepatology · 2023 · 457 citations · Eric Lawitz

5. Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.

   The New England journal of medicine · 2024 · 257 citations · Eric Lawitz

6. A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease.

   Journal of hepatology · 2023 · 185 citations · Eric Lawitz